Williams SV - Search Results

1

Assessment by M-FISH of karyotypic complexity and cytogenetic evolution in bladder cancer in vitro.

Williams SV, Adams J, Coulter J, Summersgill BM, Shipley J, Knowles MA. Williams SV, et al. Genes Chromosomes Cancer. 2005 Aug;43(4):315-28. doi: 10.1002/gcc.20166. Genes Chromosomes Cancer. 2005. PMID: 15846775

2

High-resolution deletion mapping of 15q13.2-q21.1 in transitional cell carcinoma of the bladder.

Natrajan R, Louhelainen J, Williams S, Laye J, Knowles MA. Natrajan R, et al. Cancer Res. 2003 Nov 15;63(22):7657-62. Cancer Res. 2003. PMID: 14633686

3

High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization.

Hurst CD, Fiegler H, Carr P, Williams S, Carter NP, Knowles MA. Hurst CD, et al. Oncogene. 2004 Mar 18;23(12):2250-63. doi: 10.1038/sj.onc.1207260. Oncogene. 2004. PMID: 14968109

4

Molecular genetic analysis of chromosome 9 candidate tumor-suppressor loci in bladder cancer cell lines.

Williams SV, Sibley KD, Davies AM, Nishiyama H, Hornigold N, Coulter J, Kennedy WJ, Skilleter A, Habuchi T, Knowles MA. Williams SV, et al. Genes Chromosomes Cancer. 2002 May;34(1):86-96. doi: 10.1002/gcc.10050. Genes Chromosomes Cancer. 2002. PMID: 11921286

5

Loss of heterozygosity analysis and DNA copy number measurement on 8p in bladder cancer reveals two mechanisms of allelic loss.

Adams J, Williams SV, Aveyard JS, Knowles MA. Adams J, et al. Among authors: williams sv. Cancer Res. 2005 Jan 1;65(1):66-75. Cancer Res. 2005. PMID: 15665280

6

Integrated genomic and transcriptional analysis of the in vitro evolution of telomerase-immortalized urothelial cells (TERT-NHUC).

Chapman EJ, Williams SV, Platt FM, Hurst CD, Chambers P, Roberts P, Knowles MA. Chapman EJ, et al. Among authors: williams sv. Genes Chromosomes Cancer. 2009 Aug;48(8):694-710. doi: 10.1002/gcc.20672. Genes Chromosomes Cancer. 2009. PMID: 19405089

7

High-resolution analysis of genomic alteration on chromosome arm 8p in urothelial carcinoma.

Williams SV, Platt FM, Hurst CD, Aveyard JS, Taylor CF, Pole JC, Garcia MJ, Knowles MA. Williams SV, et al. Genes Chromosomes Cancer. 2010 Jul;49(7):642-59. doi: 10.1002/gcc.20775. Genes Chromosomes Cancer. 2010. PMID: 20461757

8

Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification.

Hurst CD, Tomlinson DC, Williams SV, Platt FM, Knowles MA. Hurst CD, et al. Among authors: williams sv. Oncogene. 2008 Apr 24;27(19):2716-27. doi: 10.1038/sj.onc.1210934. Epub 2007 Nov 26. Oncogene. 2008. PMID: 18037967 Free PMC article.

9

Oncogenic FGFR3 gene fusions in bladder cancer.

Williams SV, Hurst CD, Knowles MA. Williams SV, et al. Hum Mol Genet. 2013 Feb 15;22(4):795-803. doi: 10.1093/hmg/dds486. Epub 2012 Nov 21. Hum Mol Genet. 2013. PMID: 23175443 Free PMC article.

10

A place for precision medicine in bladder cancer: targeting the FGFRs.

di Martino E, Tomlinson DC, Williams SV, Knowles MA. di Martino E, et al. Among authors: williams sv. Future Oncol. 2016 Oct;12(19):2243-63. doi: 10.2217/fon-2016-0042. Epub 2016 Jul 6. Future Oncol. 2016. PMID: 27381494 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters